Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eletriptan HBr in Early Acute Spinal Cord Injury
NCT06677229Phase 2Recruiting
- Sponsor
- TechnoPhage
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eletriptan in spinal cord injury (SCI), sponsored by TechnoPhage. Started Aug 2025; status: recruiting.
02
Drugs
eletriptan
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT06677229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677229.